Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers
Status:
Recruiting
Trial end date:
2020-08-27
Target enrollment:
Participant gender:
Summary
This study is to evaluate the bioequivalence of Oseltamivir Phosphate Capsules 75 mg versus
TAMIFLU 75 mg capsules administered as 75 mg capsules in healthy volunteers under Fed
condition.